SODIUM CHLORIDE 14.6% Drug Patent Profile
✉ Email this page to a colleague
When do Sodium Chloride 14.6% patents expire, and when can generic versions of Sodium Chloride 14.6% launch?
Sodium Chloride 14.6% is a drug marketed by Fresenius Kabi Usa and Hospira and is included in two NDAs.
The generic ingredient in SODIUM CHLORIDE 14.6% is sodium chloride. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.
Summary for SODIUM CHLORIDE 14.6%
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SODIUM CHLORIDE 14.6% at DailyMed |
Pharmacology for SODIUM CHLORIDE 14.6%
Drug Class | Osmotic Laxative |
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Anatomical Therapeutic Chemical (ATC) Classes for SODIUM CHLORIDE 14.6%
US Patents and Regulatory Information for SODIUM CHLORIDE 14.6%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Kabi Usa | SODIUM CHLORIDE 14.6% | sodium chloride | SOLUTION;INTRAVENOUS | 212070-001 | Apr 28, 2021 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | SODIUM CHLORIDE 14.6% | sodium chloride | SOLUTION;INTRAVENOUS | 018897-002 | Jul 20, 1984 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Fresenius Kabi Usa | SODIUM CHLORIDE 14.6% | sodium chloride | SOLUTION;INTRAVENOUS | 212070-002 | Apr 28, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hospira | SODIUM CHLORIDE 14.6% | sodium chloride | SOLUTION;INTRAVENOUS | 018897-001 | Jul 20, 1984 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |